Volume Status in Patients on Peritoneal Dialysis: The Role of Apelin and Bio-Impedance Spectroscopy

REFERENCES

• Lo WK, Bargman JM, Burkart J, . for the ISPD Adequacy of Peritoneal Dialysis Working Group. ISPD Guidelines/Recommendations. Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis. Perit Dial Int. 2006;26:520–522.
   PubMed Web of Science ®Google Scholar
• Paniagua R, Ventura MD, Avila-Díaz M, . NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients. Nephrol Dial Transplant. 2010;25:551–557.
   PubMed Web of Science ®Google Scholar
• Lin X, Lin A, Ni Z, . Daily peritoneal ultrafiltration predicts patient and technique survival in anuric peritoneal dialysis patients. Nephrol Dial Transplant. 2010;25:2322–2327.
   PubMed Web of Science ®Google Scholar
• Abraham G, Kumar V, Nayak KS, . Predictors of long-term survival on peritoneal dialysis in South India: A multicenter study. Perit Dial Int. 2010;30:29–34.
   PubMed Web of Science ®Google Scholar
• Masalska T, Marcelli D. The mortality risk of overhydration in hemodialysis patients. Nephrol Dial Transplant. 2009;24:1574–1579.
   PubMedGoogle Scholar
• Wang MC, Tseng CC, Tsai WC, Huang JJ. Blood pressure and left ventricular hypertrophy in patients on different peritoneal dialysis regimens. Perit Dial Int. 2001;21:36–42.
   PubMed Web of Science ®Google Scholar
• Wang AY, Wang M, Lam CW, Chan IH, Lui SF, Sanderson JE. Heart failure in long-term peritoneal dialysis patients: A 4-year prospective analysis. Clin J Am Soc Nephrol. 2011;6:805–812.
   PubMed Web of Science ®Google Scholar
• Ateş K, Nergizoğlu G, Keven K, . Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int. 2001;60:767–776.
   PubMed Web of Science ®Google Scholar
• Papakrivopoulou E, Lillywhite S, Davenport A. Is N-terminal probrain-type natriuretic peptide a clinically useful biomarker of volume overload in peritoneal dialysis patients? Nephrol Dial Transplant. 2012;27:396–401.
   PubMed Web of Science ®Google Scholar
• Arkouche W, Fouque D, Pachiaudi C, . Total body water and body composition in chronic peritoneal dialysis patients. J Am Soc Nephrol. 1997;8:1906–1914.
   PubMedGoogle Scholar
• Earthman C, Traughber D, Dobratz J, Howell W. Bioimpedance spectroscopy for clinical assessment of fluid distribution and body cell mass. Nutr Clin Pract. 2007;22:389–405.
   PubMed Web of Science ®Google Scholar
• Crepaldi C, Soni S, Chionh CY, Wabel P, Cruz DN, Ronco C. Application of body composition monitoring to peritoneal dialysis patients. Contrib Nephrol. 2009;163:1–6.
   PubMed Web of Science ®Google Scholar
• O’Dowd BF, Heiber M, Chan A, . A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene. 1993;136:355–360.
   PubMed Web of Science ®Google Scholar
• Tatemoto K, Hosoya M, Habata Y, . Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun. 1998;251:471–476.
   PubMed Web of Science ®Google Scholar
• Ladeiras-Lopes R, Ferreira-Martins J, Leite-Moreira AF. The apelinergic system: The role played in human physiology and pathology and potential therapeutic applications. Arq Bras Cardiol. 2008;90:343–349.
   PubMed Web of Science ®Google Scholar
• Kleinz MJ, Skepper JN, Davenport AP. Immunocytochemical localization of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells. Regul Pept. 2005;126:233–240.
   PubMed Web of Science ®Google Scholar
• Tatemoto K, Takayama K, Zou MX, . The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept. 2001;99:87–92.
   PubMed Web of Science ®Google Scholar
• Katugampola SD, Maguire JJ, Matthewson SR, Davenport AP. [(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man. Br J Pharmacol. 2001;132:1255–1260.
   PubMed Web of Science ®Google Scholar
• Szakodi I, Tavi P, Földes G, . Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res. 2002;91:434–440.
   PubMedGoogle Scholar
• Taheri S, Murphy K, Cohen M, . The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochem Biophys Res Commun. 2002;291:1208–1212.
   PubMed Web of Science ®Google Scholar
• Chandrasekaran B, Dar O, McDonagh T. The role of apelin in cardiovascular function and heart failure. Eur J Heart Fail. 2008;10:725–732.
   PubMed Web of Science ®Google Scholar
• Malyszko J, Malyszko JS, Kozminski P, Mysliwiec M. Apelin and cardiac function in hemodialyzed patients: Possible relations? Am J Nephrol. 2006;26:121–126.
   PubMed Web of Science ®Google Scholar
• El-Shehaby AM, El-Khatib MM, Battah AA, Roshdy AR. Apelin: A potential link between inflammation and cardiovascular disease in end stage renal disease patients. Scand J Clin Lab Invest. 2010;70:421–427.
   PubMed Web of Science ®Google Scholar
• Hus-Citharel A, Bouby N, Frugière A, Bodineau L, Gasc JM, Llorens-Cortes C. Effect of apelin on glomerular hemodynamic function in the rat kidney. Kidney Int. 2008;74:486–494.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Reichek N. Echocaridographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977;55:613–618.
   PubMed Web of Science ®Google Scholar
• John B, Tan BK, Dainty S, Spanel P, Smith D, Davies SJ. Plasma volume, albumin, and fluid status in peritoneal dialysis patients. Clin J Am Soc Nephrol. 2010;5:1463–1470.
   PubMed Web of Science ®Google Scholar
• Onofriescu M, Mardare NG, Segall L, . Randomized trial of bioelectrical impedance analysis versus clinical criteria for guiding ultrafiltration in hemodialysis patients: Effects on blood pressure, hydration status, and arterial stiffness. Int Urol Nephrol. 2012;44:583–591.
   PubMed Web of Science ®Google Scholar
• Machek P, Jirka T, Moissl U, Chamney P, Wabel P. Guided optimization of fluid status in hemodialysis patients. Nephrol Dial Transplant. 2010;25:538–544.
   PubMed Web of Science ®Google Scholar
• Sipahi S, Hur E, Demirtas S, . Body composition monitor measurement technique for the detection of volume status in peritoneal dialysis patients: The effect of abdominal fullness. Int Urol Nephrol. 2011;43:1195–1199.
   PubMed Web of Science ®Google Scholar
• Kleinz MJ, Davenport AP. Emerging roles of apelin in biology and medicine. Pharmacol Ther. 2005;107:198–211.
   PubMed Web of Science ®Google Scholar
• Chong KS, Gardner RS, Morton JJ, Ashley EA, McDonagh TA. Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure. Eur J Heart Fail. 2006;8:355–360.
   PubMed Web of Science ®Google Scholar
• Chen MM, Ashley EA, Deng DX, . Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation. 2003;108:1432–1439.
   PubMed Web of Science ®Google Scholar
• Tasci I, Erdem G, Ozgur G, . LDL-cholesterol lowering increases plasma apelin in isolated hypercholesterolemia. Atherosclerosis. 2009;204:222–228.
   PubMed Web of Science ®Google Scholar
• Tasci I, Dogru T, Naharci I, . Plasma apelin is lower in patients with elevated LDL-cholesterol. Exp Clin Endocrinol Diabetes. 2007;115:428–432.
   PubMed Web of Science ®Google Scholar
• Tsimihodimos V, Mitrogianni Z, Elisaf M. Dyslipidemia associated with chronic kidney disease. Open Cardiovasc Med J. 2011;5:41–48.
   PubMedGoogle Scholar